Overall Score

Revenue Quality

Gross margin remains healthy at 51.2%, supporting a solid core revenue model.

Revenue efficiency is still decent with price-to-sales at 1.14x and asset turnover at 0.85x.

Receivables remain manageable with days sales outstanding at 55.9 days.

Profitability

Operating margin is thin at 5.96% and EBIT margin is only 1.69%, indicating limited operating leverage.

Net margin is just 1.27%, so earnings conversion remains weak despite decent gross profit.

Return on equity is low at 2.48% and return on assets is only 1.08%.

Cash Generation

Free cash flow yield is solid at 10.7%, and price-to-free-cash-flow is a reasonable 9.38x.

Operating cash flow coverage remains healthy, with operating cash flow ratio at 0.76x and capital expenditure coverage near 10.0x.

Cash conversion cycle is positive at 9.4 days, suggesting working capital is not a major drag.

Balance Sheet

Current ratio is 1.78x and quick ratio is 1.77x, indicating adequate short-term liquidity.

Leverage is moderate with debt-to-equity at 0.94x and debt-to-assets at 0.41x.

Interest coverage is acceptable at 3.27x, but net debt to EBITDA remains elevated at 4.09x.

Capital Allocation

Capex intensity is low at 1.35% of revenue, leaving room for discretionary capital deployment.

Stock-based compensation is moderate at 4.93% of revenue, which is not overly dilutive but still meaningful.

Return on invested capital is deeply negative at -54.9%, suggesting capital allocation has not yet translated into strong economic returns.